274 related articles for article (PubMed ID: 21493702)
1. IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
Cardiovasc Res; 2011 Aug; 91(3):456-64. PubMed ID: 21493702
[TBL] [Abstract][Full Text] [Related]
2. Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.
Jochmann S; Elkenani M; Mohamed BA; Buchholz E; Lbik D; Binder L; Lorenz K; Shah AM; Hasenfuß G; Toischer K; Schnelle M
ESC Heart Fail; 2019 Oct; 6(5):1015-1026. PubMed ID: 31322843
[TBL] [Abstract][Full Text] [Related]
3. ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1.
Sbroggiò M; Bertero A; Velasco S; Fusella F; De Blasio E; Bahou WF; Silengo L; Turco E; Brancaccio M; Tarone G
J Cell Sci; 2011 Oct; 124(Pt 20):3515-24. PubMed ID: 22010199
[TBL] [Abstract][Full Text] [Related]
4. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical scaffolding of an ERK1/2 activation pathway.
Vetterkind S; Poythress RH; Lin QQ; Morgan KG
Cell Commun Signal; 2013 Aug; 11():65. PubMed ID: 23987506
[TBL] [Abstract][Full Text] [Related]
6. The WW domain of the scaffolding protein IQGAP1 is neither necessary nor sufficient for binding to the MAPKs ERK1 and ERK2.
Bardwell AJ; Lagunes L; Zebarjedi R; Bardwell L
J Biol Chem; 2017 May; 292(21):8750-8761. PubMed ID: 28396345
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
Li J; Yousefi K; Ding W; Singh J; Shehadeh LA
Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726
[TBL] [Abstract][Full Text] [Related]
9. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload.
De Acetis M; Notte A; Accornero F; Selvetella G; Brancaccio M; Vecchione C; Sbroggiò M; Collino F; Pacchioni B; Lanfranchi G; Aretini A; Ferretti R; Maffei A; Altruda F; Silengo L; Tarone G; Lembo G
Circ Res; 2005 May; 96(10):1087-94. PubMed ID: 15860758
[TBL] [Abstract][Full Text] [Related]
10. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
Roy M; Li Z; Sacks DB
Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
[TBL] [Abstract][Full Text] [Related]
11. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
12. rAAV9-Mediated MEK1 Gene Expression Restores Post-conditioning Protection Against Ischemia Injury in Hypertrophic Myocardium.
Chen Y; Liu F; Chen BD; Li XM; Huang Y; Yu ZX; Gao XL; He CH; Yang YN; Ma YT; Gao XM
Cardiovasc Drugs Ther; 2020 Feb; 34(1):3-14. PubMed ID: 32103377
[TBL] [Abstract][Full Text] [Related]
13. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
[TBL] [Abstract][Full Text] [Related]
14. In vivo cardiac role of migfilin during experimental pressure overload.
Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
[TBL] [Abstract][Full Text] [Related]
15. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin prevents cardiac cell apoptosis during cardiac remodelling post experimentally induced myocardial infarction in rats via activation of Raf-MEK1/2-ERK1/2 signalling.
Eid RA; Alkhateeb MA; Al-Shraim M; Eleawa SM; Shatoor AS; El-Kott AF; Zaki MSA; Shatoor KA; Bin-Jaliah I; Al-Hashem FH
Arch Physiol Biochem; 2019 May; 125(2):93-103. PubMed ID: 29447000
[TBL] [Abstract][Full Text] [Related]
17. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.
Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K
Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947
[TBL] [Abstract][Full Text] [Related]
18. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
19. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
[TBL] [Abstract][Full Text] [Related]
20. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]